Annual ROE
11.57%
+145.70%+108.63%
31 December 2023
Summary:
TG Therapeutics annual return on equity is currently 11.57%, with the most recent change of +145.70% (+108.63%) on 31 December 2023. During the last 3 years, it has risen by +111.71% (+111.55%). TGTX annual ROE is now -88.14% below its all-time high of 97.55%, reached on 31 December 2008.TGTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-8.40%
-76.42%-112.35%
30 September 2024
Summary:
TG Therapeutics quarterly return on equity is currently -8.40%, with the most recent change of -76.42% (-112.35%) on 30 September 2024. Over the past year, it has increased by +24.67% (+74.60%). TGTX quarterly ROE is now -101.13% below its all-time high of 742.44%, reached on 30 June 2008.TGTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +108.6% | +74.6% |
| 3 y3 years | +111.5% | +91.0% |
| 5 y5 years | +103.0% | +99.1% |
TGTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +108.6% | -112.3% | +96.6% |
| 5 y | 5 years | at high | +102.1% | -112.3% | +99.6% |
| alltime | all time | -88.1% | +100.3% | -101.1% | +99.9% |
TG Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -8.40%(-112.3%) |
| June 2024 | - | 68.02%(+82.7%) |
| Mar 2024 | - | 37.23%(+165.4%) |
| Dec 2023 | 11.57%(-108.6%) | 14.03%(-142.4%) |
| Sept 2023 | - | -33.07%(-86.6%) |
| June 2023 | - | -246.71%(+42.2%) |
| Mar 2023 | - | -173.44%(+21.7%) |
| Dec 2022 | -134.13%(+45.7%) | -142.56%(+13.3%) |
| Sept 2022 | - | -125.81%(+7.4%) |
| June 2022 | - | -117.16%(+11.1%) |
| Mar 2022 | - | -105.49%(+14.9%) |
| Dec 2021 | -92.03%(-8.1%) | -91.78%(-2.1%) |
| Sept 2021 | - | -93.71%(-6.8%) |
| June 2021 | - | -100.58%(-16.2%) |
| Mar 2021 | - | -120.05%(-20.8%) |
| Dec 2020 | -100.14%(-81.9%) | -151.59%(-50.5%) |
| Sept 2020 | - | -306.54%(-34.7%) |
| June 2020 | - | -469.39%(-78.2%) |
| Mar 2020 | - | -2149.23%(+72.4%) |
| Dec 2019 | -551.85%(+44.8%) | -1246.92%(+36.5%) |
| Sept 2019 | - | -913.43%(+163.5%) |
| June 2019 | - | -346.62%(+25.1%) |
| Mar 2019 | - | -277.00%(+11.6%) |
| Dec 2018 | -381.16%(+65.5%) | -248.27%(+33.6%) |
| Sept 2018 | - | -185.83%(+3.2%) |
| June 2018 | - | -180.08%(+11.8%) |
| Mar 2018 | - | -161.01%(-1.8%) |
| Dec 2017 | -230.36%(+102.3%) | -163.90%(+3.4%) |
| Sept 2017 | - | -158.45%(+6.2%) |
| June 2017 | - | -149.26%(+17.2%) |
| Mar 2017 | - | -127.32%(+17.9%) |
| Dec 2016 | -113.87%(+64.3%) | -107.98%(+32.5%) |
| Sept 2016 | - | -81.52%(+33.3%) |
| June 2016 | - | -61.14%(+3.5%) |
| Mar 2016 | - | -59.09%(-2.9%) |
| Dec 2015 | -69.30%(-25.4%) | -60.86%(-8.4%) |
| Sept 2015 | - | -66.44%(-18.1%) |
| June 2015 | - | -81.17%(-7.0%) |
| Mar 2015 | - | -87.25%(-8.1%) |
| Dec 2014 | -92.85%(+26.1%) | -94.94%(+15.0%) |
| Sept 2014 | - | -82.56%(+11.8%) |
| June 2014 | - | -73.83%(-0.5%) |
| Mar 2014 | - | -74.20%(-9.3%) |
| Dec 2013 | -73.66%(-48.7%) | -81.77%(-7.8%) |
| Sept 2013 | - | -88.66%(-14.3%) |
| June 2013 | - | -103.45%(+60.5%) |
| Mar 2013 | - | -64.47%(-40.0%) |
| Dec 2012 | -143.51%(+259.3%) | -107.51%(-3.2%) |
| Sept 2012 | - | -111.10%(-15.9%) |
| June 2012 | - | -132.06%(-35.6%) |
| Mar 2012 | - | -205.14%(-98.2%) |
| Dec 2011 | -39.94%(+243.4%) | -11.40 K%(-2449.3%) |
| Sept 2011 | - | 485.31%(+60.7%) |
| June 2011 | - | 301.95%(+55.1%) |
| Mar 2011 | - | 194.72%(-2005.3%) |
| Dec 2010 | -11.63% | -10.22%(+1758.2%) |
| Sept 2010 | - | -0.55%(-108.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | 6.31%(-88.3%) |
| Mar 2010 | - | 53.78%(+19.1%) |
| Dec 2009 | 41.17%(-57.8%) | 45.16%(+3.2%) |
| Sept 2009 | - | 43.77%(-34.6%) |
| June 2009 | - | 66.95%(-14.7%) |
| Mar 2009 | - | 78.51%(-40.5%) |
| Dec 2008 | 97.55%(-102.5%) | 131.96%(-50.6%) |
| Sept 2008 | - | 267.38%(-64.0%) |
| June 2008 | - | 742.44%(-224.8%) |
| Mar 2008 | - | -595.01%(+9.5%) |
| Dec 2007 | -3922.22%(+2134.2%) | -543.45%(+30.1%) |
| Sept 2007 | - | -417.84%(+39.0%) |
| June 2007 | - | -300.55%(+52.7%) |
| Mar 2007 | - | -196.82%(+11.4%) |
| Dec 2006 | -175.55%(-35.8%) | -176.61%(+44.3%) |
| Sept 2006 | - | -122.39%(-7.4%) |
| June 2006 | - | -132.19%(-58.2%) |
| Mar 2006 | - | -316.46%(-3.4%) |
| Dec 2005 | -273.55%(+161.8%) | -327.72%(-7.8%) |
| Sept 2005 | - | -355.33%(-13.2%) |
| June 2005 | - | -409.36%(+310.9%) |
| Mar 2005 | - | -99.63%(+18.2%) |
| Dec 2004 | -104.48%(-34.5%) | -84.32%(-11.3%) |
| Sept 2004 | - | -95.07%(-25.9%) |
| June 2004 | - | -128.38%(-18.1%) |
| Mar 2004 | - | -156.78%(-33.7%) |
| Dec 2003 | -159.58%(+45.2%) | -236.63%(-36.3%) |
| Sept 2003 | - | -371.36%(+223.7%) |
| June 2003 | - | -114.72%(+6.5%) |
| Mar 2003 | - | -107.71%(-48.8%) |
| Dec 2002 | -109.91%(-25.7%) | -210.37%(-50.7%) |
| Sept 2002 | - | -426.79%(+11.9%) |
| June 2002 | - | -381.28%(-17.0%) |
| Mar 2002 | - | -459.54%(+160.3%) |
| Dec 2001 | -147.92%(-42.7%) | -176.57%(+30.9%) |
| Sept 2001 | - | -134.85%(+21.2%) |
| June 2001 | - | -111.30%(-12.3%) |
| Mar 2001 | - | -126.92%(-47.5%) |
| Dec 2000 | -258.11%(+400.1%) | -241.63%(+19.3%) |
| Sept 2000 | - | -202.47%(+29.7%) |
| June 2000 | - | -156.11%(+117.5%) |
| Mar 2000 | - | -71.77%(+35.2%) |
| Dec 1999 | -51.61%(+31.8%) | -53.10%(-9.9%) |
| Sept 1999 | - | -58.94%(-10.1%) |
| June 1999 | - | -65.57%(+82.5%) |
| Mar 1999 | - | -35.93%(-5.5%) |
| Dec 1998 | -39.16%(-60.5%) | -38.04%(+3.5%) |
| Sept 1998 | - | -36.76%(-5.7%) |
| June 1998 | - | -39.00%(-59.6%) |
| Mar 1998 | - | -96.55%(-11.3%) |
| Dec 1997 | -99.05%(-42.2%) | -108.79%(-13.9%) |
| Sept 1997 | - | -126.34%(-41.0%) |
| June 1997 | - | -214.29%(+26.9%) |
| Mar 1997 | - | -168.89%(+17.2%) |
| Dec 1996 | -171.43% | -144.16%(+49.5%) |
| Sept 1996 | - | -96.43%(+50.7%) |
| June 1996 | - | -64.00% |
FAQ
- What is TG Therapeutics annual return on equity?
- What is the all time high annual ROE for TG Therapeutics?
- What is TG Therapeutics annual ROE year-on-year change?
- What is TG Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for TG Therapeutics?
- What is TG Therapeutics quarterly ROE year-on-year change?
What is TG Therapeutics annual return on equity?
The current annual ROE of TGTX is 11.57%
What is the all time high annual ROE for TG Therapeutics?
TG Therapeutics all-time high annual return on equity is 97.55%
What is TG Therapeutics annual ROE year-on-year change?
Over the past year, TGTX annual return on equity has changed by +145.70% (+108.63%)
What is TG Therapeutics quarterly return on equity?
The current quarterly ROE of TGTX is -8.40%
What is the all time high quarterly ROE for TG Therapeutics?
TG Therapeutics all-time high quarterly return on equity is 742.44%
What is TG Therapeutics quarterly ROE year-on-year change?
Over the past year, TGTX quarterly return on equity has changed by +24.67% (+74.60%)